ARCH Venture Management, LLC

CIK 0001274403 · CHICAGO, IL · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

ARCH Venture Management, LLC reported 12 positions worth $1.10B as of June 30, 2026 (13F filed August 14, 2026). Largest holding: PBLS (16.0%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$1.10B
2026 Q2
Positions
12
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
99.3%
Est. Net Flow (Q)
2026 Q2
10 / 12 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1PBLSPARABILIS MEDICINES INCSH$175.5M15.95%6,412,780
2BEAMBEAM THERAPEUTICS INCSH$155.8M14.16%4,540,132
3RAPPRAPPORT THERAPEUTICS INCSH$155.4M14.12%3,728,738
4SPTXSEAPORT THERAPEUTICS INCSH$136.6M12.42%6,294,951
5ERASERASCA INCSH$129.9M11.81%7,091,557
6VIRVIR BIOTECHNOLOGY INCSH$129.4M11.76%12,694,163
7MAZEMAZE THERAPEUTICS INCSH$123.0M11.18%4,120,053
8LYELLYELL IMMUNOPHARMA INCSH$45.5M4.14%3,247,162
9GENBGENERATE BIOMEDICINES INCSH$32.8M2.98%1,944,426
10TXG10X GENOMICS INCSH$8.4M0.76%217,834

The free plan shows the top 10 positions. The remaining 2 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does ARCH Venture Management, LLC hold as of Q2 2026?

ARCH Venture Management, LLC reported 12 positions worth $1.10B in its Q2 2026 13F filing. Largest positions: PBLS (16.0%), BEAM (14.2%), RAPP (14.1%), SPTX (12.4%) and ERAS (11.8%).

What did ARCH Venture Management, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did ARCH Venture Management, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.